Chargement en cours...
Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC‐202 blocks oncogenic hedgehog‐GLI signaling and overcomes smoothened inhibitor resistance
Aberrant activation of Hedgehog (HH)/GLI signaling is causally involved in numerous human malignancies, including basal cell carcinoma (BCC) and medulloblastoma. HH pathway antagonists targeting smoothened (SMO), an essential effector of canonical HH/GLI signaling, show significant clinical success...
Enregistré dans:
| Publié dans: | Int J Cancer |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5813224/ https://ncbi.nlm.nih.gov/pubmed/29055107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31117 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|